BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 9266617)

  • 21. Interactions between narcotic analgesics and benzodiazepine derivatives on behavior in the mouse.
    Shannon HE; Holtzman SG; Davis DC
    J Pharmacol Exp Ther; 1976 Nov; 199(2):389-99. PubMed ID: 10428
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interactions between LY354740, a group II metabotropic agonist and the GABA(A)-benzodiazepine receptor complex in the rat elevated plus-maze.
    Ferris P; Seward E; Dawson GR
    J Psychopharmacol; 2001 Jun; 15(2):76-82. PubMed ID: 11448091
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Selective interaction of homophtalazine derivatives with morphine.
    Fekete MI; Horváth K; Kedves R; Máté I; Székely JI; Szentkuti E
    Eur J Pharmacol; 1997 Jul; 331(2-3):175-83. PubMed ID: 9274977
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Involvement of the opioid system in the anxiolytic effect of diazepam in mice.
    Tsuda M; Suzuki T; Misawa M; Nagase H
    Eur J Pharmacol; 1996 Jun; 307(1):7-14. PubMed ID: 8831097
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dextro-naloxone counteracts amphetamine-induced hyperactivity.
    Chatterjie N; Sechzer JA; Lieberman KW; Alexander GJ
    Pharmacol Biochem Behav; 1998 Feb; 59(2):271-4. PubMed ID: 9476969
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Relations between open-field, elevated plus-maze, and emergence tests in C57BL/6J and BALB/c mice injected with GABA- and 5HT-anxiolytic agents.
    Lalonde R; Strazielle C
    Fundam Clin Pharmacol; 2010 Jun; 24(3):365-76. PubMed ID: 19735300
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Preliminary report of a simple animal behavior model for the anxiolytic effects of benzodiazepines.
    Crawley J; Goodwin FK
    Pharmacol Biochem Behav; 1980 Aug; 13(2):167-70. PubMed ID: 6106204
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The role of opioid system in peculiarities of anti-anxiety effect of peptide anxiolytic selank].
    Kozlovskiĭ II; Andreeva LA; Kozlovskaia MM; Nadorova AV; Kolik LG
    Eksp Klin Farmakol; 2012; 75(2):10-3. PubMed ID: 22550852
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differential effects of benzodiazepines and amphetamine on exploratory behaviour in weanling rats: an animal model for anxiolytic activity.
    Salt JS; Taberner PV
    Prog Neuropsychopharmacol Biol Psychiatry; 1984; 8(1):163-9. PubMed ID: 6145184
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of opioidergic systems upon anxiolytic-like behaviors induced in cholestatic rats.
    Eslimi D; Oryan S; Nasehi M; Zarrindast MR
    Eur J Pharmacol; 2011 Nov; 670(1):180-5. PubMed ID: 21914447
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Riluzole produces distinct anxiolytic-like effects in rats without the adverse effects associated with benzodiazepines.
    Sugiyama A; Saitoh A; Iwai T; Takahashi K; Yamada M; Sasaki-Hamada S; Oka J; Inagaki M; Yamada M
    Neuropharmacology; 2012 Jun; 62(8):2489-98. PubMed ID: 22377384
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effect of opiodergic system and testosterone on anxiety behavior in gonadectomized rats.
    Khakpai F
    Behav Brain Res; 2014 Apr; 263():9-15. PubMed ID: 24468308
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characterization of the behavioral profile of the non-peptide CRF receptor antagonist CP-154,526 in anxiety models in rodents. Comparison with diazepam and buspirone.
    Griebel G; Perrault G; Sanger DJ
    Psychopharmacology (Berl); 1998 Jul; 138(1):55-66. PubMed ID: 9694527
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Schedule dependence of the interaction of naloxone and chlordiazepoxide.
    Tripp G; McNaughton N
    Pharmacol Biochem Behav; 1992 Mar; 41(3):475-81. PubMed ID: 1584829
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Naloxone does not attenuate the locomotor effects of ethanol in FAST, SLOW, or two heterogeneous stocks of mice.
    Holstein SE; Pastor R; Meyer PJ; Phillips TJ
    Psychopharmacology (Berl); 2005 Oct; 182(2):277-89. PubMed ID: 15990998
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cholecystokinin antagonism by benzodiazepines in the food intake in mice.
    Kubota K; Matsuda I; Sugaya K; Uruno T
    Physiol Behav; 1986 Jan; 36(1):175-8. PubMed ID: 2869533
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Naloxone blocks the effect of diazepam and meprobamate on conflict behaviour in rats.
    Duka T; Cumin R; Haefely W; Herz A
    Pharmacol Biochem Behav; 1981 Jul; 15(1):115-7. PubMed ID: 7291219
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A Pharmacogenetic 'Restriction-of-Function' Approach Reveals Evidence for Anxiolytic-Like Actions Mediated by α5-Containing GABAA Receptors in Mice.
    Behlke LM; Foster RA; Liu J; Benke D; Benham RS; Nathanson AJ; Yee BK; Zeilhofer HU; Engin E; Rudolph U
    Neuropsychopharmacology; 2016 Sep; 41(10):2492-501. PubMed ID: 27067130
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Naloxone blocks the effects of chlordiazepoxide on acquisition but not performance of differential reinforcement of low rates of response (DRL).
    Tripp G; McNaughton N; Oei TP
    Psychopharmacology (Berl); 1987; 91(1):112-8. PubMed ID: 2881314
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Changes in head-dipping behavior in the hole-board test reflect the anxiogenic and/or anxiolytic state in mice.
    Takeda H; Tsuji M; Matsumiya T
    Eur J Pharmacol; 1998 May; 350(1):21-9. PubMed ID: 9683010
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.